| Citation: |
WANG Qiushi, YU Hui, LI Xiang, ZHANG Heng. Effect of stereotactic hematoma puncture aspiration combined with edaravone in treatment of patients with cerebral hemorrhage in Neurosurgery Intensive Care Unit[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 88-92, 98. DOI: 10.7619/jcmp.20233448
|
To explore the effect of stereotactic hematoma puncture aspiration (SHPS) combined with edaravone in the treatment of patients with cerebral hemorrhage in the Neurosurgery Intensive Care Unit (NICU).
A total of 98 patients with cerebral hemorrhage in NICU were divided into experimental group and control group by drawing lots, with 49 cases in each group. The control group was treated with SHPS and conventional therapy, while the experimental group was treated with edaravone on the basis of the control group. The clinical efficacy, the quality of life[the National Institute of Health Stroke Scale (NIHSS) score, the Ability of Daily Living (ADL) score and the China Stroke Scale (CSS) score], glucose and lipid metabolism indicators[jugular venous oxygen saturation (SjvO2), arteriovenous lactate (A-VLac) and arteriovenous glucose (A-VGlu)], inflammatory factors[interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)]levels as well as incidence of complications were compared between the two groups.
The total effective rate of the experimental group was 91.84%, which was significantly higher than 77.55% of the control group (P < 0.05). After treatment, the NIHSS score and CSS score of the experimental group were significantly lower than those of the control group, while the ADL score was significantly higher than that of the control group (P < 0.05). After treatment, the SjvO2 level in the experimental group was significantly higher than that in the control group, while the levels of A-VGlu and A-VLac were significantly lower than those in the control group (P < 0.05). After treatment, the IL-8, IL-6 and TNF-α levels in the experimental group were significantly lower than those in the control group (P < 0.05). The incidence of complications in the experimental group was 12.24%, which was significantly lower than 30.61% in the control group (P < 0.05).
The combination of SHPS and edaravone can reinforce the clinical efficacy of patients with cerebral hemorrhage in NICU, improve neurological function, and reduce the incidence of postoperative complications.
| [1] |
阮升, 吴淳, 侯勇, 等. 立体定向抽吸联合肾上腺素灌洗治疗基底节区高血压性脑出血的疗效[J]. 浙江临床医学, 2021, 23(10): 1416-1418, 1421. doi: 10.3969/j.issn.1008-7664.2021.10.010
|
| [2] |
MAO Y M, SHEN Z M, ZHU H F, et al. Observation on therapeutic effect of stereotactic soft channel puncture and drainage on hypertensive cerebral hemorrhage[J]. Ann Palliat Med, 2020, 9(2): 339-345. doi: 10.21037/apm.2020.03.12
|
| [3] |
HAWKES M A, RABINSTEIN A A. Acute hypertensive response in patients with acute intracerebral hemorrhage: a narrative review[J]. Neurology, 2021, 97(7): 316-329. doi: 10.1212/WNL.0000000000012276
|
| [4] |
朱红倩, 郭媛媛, 刘雷. 血肿腔穿刺引流联合醒脑静注射液在急性脑出血患者中的应用及对血清SF、MBP、GFAP的影响研究[J]. 川北医学院学报, 2021, 36(4): 509-512. doi: 10.3969/j.issn.1005-3697.2021.04.024
|
| [5] |
MIAO H P, JIANG Y X, GENG J J, et al. Edaravone administration confers neuroprotection after experimental intracerebral hemorrhage in rats via NLRP3 suppression[J]. J Stroke Cerebrovasc Dis, 2020, 29(1): 104468. doi: 10.1016/j.jstrokecerebrovasdis.2019.104468
|
| [6] |
中华医学会神经外科学分会, 中国医师协会急诊医师分会, 中华医学会神经病学分会脑血管病学组, 等. 高血压性脑出血中国多学科诊治指南[J]. 中华神经外科杂志, 2020, 36(8): 757-770. doi: 10.3760/cma.j.cn112050-20200510-00282
|
| [7] |
廖云, 盛敏峰, 王中勇, 等. 神经内镜下经额锁孔入路与显微镜下经颞锁孔入路手术治疗基底节区脑出血的疗效比较[J]. 中华神经医学杂志, 2021, 20(11): 1124-1129. doi: 10.3760/cma.j.cn115354-20210621-00390
|
| [8] |
PASHMDARFARD M, AZAD A. Assessment tools to evaluate Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) in older adults: a systematic review[J]. Med J Islam Repub Iran, 2020, 34: 33.
|
| [9] |
卓健伟, 杨理坤, 朱洁, 等. 阿托伐他汀对慢性硬膜下血肿患者术后MBI、CSS评分的影响[J]. 现代生物医学进展, 2020, 20(18): 3582-3586. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202018041.htm
|
| [10] |
杨春红, 安岭, 张松, 等. 微创软通道穿刺引流术与开颅血肿清除术治疗高血压性脑出血的效果比较[J]. 实用临床医药杂志, 2020, 24(17): 66-68, 72. doi: 10.7619/jcmp.202017017
|
| [11] |
SHEN J, GUO F B, YANG P, et al. Influence of hypertension classification on hypertensive intracerebral hemorrhage location[J]. J Clin Hypertens, 2021, 23(11): 1992-1999. doi: 10.1111/jch.14367
|
| [12] |
TSAI H H, LEE B C, CHEN Y F, et al. Cerebral venous reflux and dilated basal Ganglia perivascular space in hypertensive intracerebral hemorrhage[J]. J Stroke, 2022, 24(3): 363-371. doi: 10.5853/jos.2022.01004
|
| [13] |
CAO S H, WEI J T, CAI Y G, et al. Network pharmacology prediction and experimental verification for anti-ferroptosis of edaravone after experimental intracerebral hemorrhage[J]. Mol Neurobiol, 2023, 60(7): 3633-3649. doi: 10.1007/s12035-023-03279-x
|
| [14] |
DANG L F, DONG X, YANG J. Influence of nanoparticle-loaded edaravone on postoperative effects in patients with cerebral hemorrhage[J]. J Nanosci Nanotechnol, 2021, 21(2): 1202-1211.
|
| [15] |
GUO W, LIU H X, TAN Z J, et al. Comparison of endoscopic evacuation, stereotactic aspiration, and craniotomy for treatment of basal Ganglia hemorrhage[J]. J Neurointerv Surg, 2020, 12(1): 55-61. doi: 10.1136/neurintsurg-2019-014962
|
| [16] |
QIN M Z, FENG L D, YANG C, et al. Edaravone use in acute intracerebral hemorrhage: a systematic review and meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2022, 13: 935198.
|
| [17] |
李嘉, 王全力, 刘亚坤, 等. 依达拉奉联合开颅血肿清除术对中等量基底核区高血压脑出血患者神经功能的影响[J]. 中国药业, 2021, 30(3): 73-76. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGZ202103021.htm
|
| [18] |
梁韡斌, 曾敬, 郭建辉, 等. 立体定向血肿穿刺抽吸术+依达拉奉对高血压脑出血患者神经功能、糖氧代谢指标的影响[J]. 湖南师范大学学报: 医学版, 2021, 18(4): 120-123. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYG202104034.htm
|
| [19] |
石代乐, 高继英, 杨李鹏, 等. 依达拉奉配合醒脑静注射液治疗脑出血临床疗效及对神经细胞因子和炎性反应递质的影响[J]. 实用医院临床杂志, 2022, 19(4): 36-40. https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC202204010.htm
|
| [20] |
WANG H Y, XIN W Q, CUI J Z. Experience of using a new brain surgery head frame and location sticker for treating spontaneous intracranial hematoma[J]. Front Neurol, 2022, 13: 818523.
|
| [21] |
LI M, MU F Q, LIU X Z, et al. Effect western medicines combined with Nao-Xue-Shu in patients with hypertensive intracerebral hemorrhage: a network meta-analysis[J]. Front Pharmacol, 2022, 13: 892904.
|
| [22] |
ZHENG M, WANG X Y, YANG J, et al. Changes of complement and oxidative stress parameters in patients with acute cerebral infarction or cerebral hemorrhage and the clinical significance[J]. Exp Ther Med, 2020, 19(1): 703-709.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: